Epcoritamab-CAR T Cells for Large B-cell Lymphomas

Clinical trial NCT06458439 · RECRUITING

Trial details

NCT number: NCT06458439
Sponsor: Abramson Cancer Center at Penn Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Relapsed Diffuse Large B Cell Lymphoma Refractory Diffuse Large B-cell Lymphoma High-grade B-cell Lymphoma Transformed Indolent Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma

Start date: 2024-09-24
Primary completion: 2027-10-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.